financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Matador Resources Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Matador Resources Company
Apr 25, 2024 6:26 AM

09:05 AM EDT, 04/25/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target of $68, up $4, reflects a 5.9x multiple of EV to projected 2024 EBITDA, above MTDR's historical average. We think a premium is merited due to MTDR's sub-1.0x net debt-to-EBITDA ratio (0.75x). We lift our 2024 EPS view by $0.41 to $7.34 and 2025's by $0.85 to $7.89. Q1 EPS of $1.71 vs. $1.50, beat consensus by $0.16. Q1 revenue (~$788M) rose 41% Y/Y, driven by sales of purchased natural gas (+44%). Production (~150k boe/d) grew 40% Y/Y due to robust crude oil volumes (+44%). As a result, MTDR revised its 2024 production guide, with production now expected to be at the high end of its prior outlook (153k-159k boe/d vs. 131k boe/d in 2023), while keeping its capex guide intact (midpoint of $1.4B vs. $1.3B in 2023). However, we think MTDR's 2024 expectations might be too aggressive (+20% Y/Y production growth; +8% capex growth), given that its peers, by our estimation, are keeping their 2024 production levels flat from 2023 while reducing their capex spending by around 9%. Shares yield 1.2%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Copart, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Copart, Inc.
May 17, 2024
08:25 AM EDT, 05/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month target of $65, based on 38.2x our FY 25 (Jul.) EPS estimate, a justified premium to CPRT's 5-year mean forward P/E of 33.3x. We maintain our...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Take-two Interactive Software, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Take-two Interactive Software, Inc.
May 17, 2024
12:30 PM EDT, 05/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $5 to $177 on 19x our CY 2025 EPS view of $9.32, below peers and its three-year historical average reflecting tough comps, partially offset...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Inspire Medical Systems, Inc.
May 17, 2024
10:30 AM EDT, 05/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain a 12-month price target of $225, based on a '25 P/E of 300x. We raise our adjusted EPS estimates to $0.15 from -$0.40 for '24 and to $0.75...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Target Corporation
Research Alert: CFRA Keeps Hold Opinion On Shares Of Target Corporation
May 17, 2024
11:25 AM EDT, 05/17/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: TGT will report FQ1 2025 results on May 22. Sales will likely remain pressured (we forecast -3.3% comp sales) before returning to low-single-digit growth in FQ2 2025, as comps will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved